Compassionate Use of Domperidone for Refractory Gastroparesis

Part of paid clinical trials in Kansas City, Missouri.

Sponsor
Jose Cocjin
Study ID
NCT04699591
Status
Recruiting
Apply to this trial

Conditions

  • GERD
  • Gastroesophageal Reflux
  • Gastroparesis

Eligibility Criteria

Sex
ALL
Age
12 Years - 21 Years
Healthy Volunteers
Not accepted

Interventions

  • Domperidone — DRUG
    Domperidone taken 4 times a day, dose based on body weight

Study Details

The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.

Key Dates

Start date
Apr 30, 2013
Status verified
Mar 2026
Primary completion
Dec 31, 2035
Completion
Dec 31, 2035

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Overall Study
    Receive domperidone 4 times a day, weight-dependent dose

Primary Outcome Measure

Change in disease severity [ Time Frame: Up to 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Mercy Hospitals and ClinicsKansas CityMissouri64108
Corey Schurman, MA
[email protected]
816-802-1167
Jose Cocjin, MD
[email protected]
816-302-3400
Jose Cocjin, MD (PRINCIPAL_INVESTIGATOR)
John Rosen, MD (SUB_INVESTIGATOR)

Find similar trials in Kansas City, MO

By research site
Children's Mercy Hospitals and Clinics· Kansas City, MO

Related Studies